Research Article
Mechanism and Role of the Neuropeptide LGI1 Receptor ADAM23 in Regulating Biomarkers of Ferroptosis and Progression of Esophageal Cancer
Figure 3
Clinical correlation analysis. (a) A ceRNA network of esophageal cancer and ferroptosis. (b) Correlations among ADAM23, miR-372, and ARHGEF26-AS1. (c) The correlation between ADAM23 and ARHGEF26-AS1 (). (d) The correlation between ADAM23 and hsa-miR-372 (). (e) Differential expression of ADAM23 in different clinical stages. (f) Association of ADAM23, miR-372, and ARHGEF26-AS1 with FPI. (g) Distribution of ADAM23 expression in human tissues.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |